Search research articles
Contact Us
Filters
Showing results (201-210 of 225) with videos related to
Page
of 23
Sort By:
Annals of Internal Medicine
|
December 6, 2017
Whole-Exome Sequencing in Adults With Chronic Kidney Disease: A Pilot Study
Sneh Lata, Maddalena Marasa, Yifu Li, et al.
Autoimmunity Reviews
|
September 17, 2020
Rituximab in adult minimal change disease and focal segmental glomerulosclerosis - What is known and what is still unknown?
Philipp Gauckler, Jae Il Shin, Federico Alberici, et al.
Lancet (London, England)
|
November 6, 2023
Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial
Brad H Rovin, Jonathan Barratt, Hiddo J L Heerspink, et al.
Plos One
|
December 28, 2020
High rate of renal recovery in survivors of COVID-19 associated acute renal failure requiring renal replacement therapy
Jacob S Stevens, Kristen L King, Shelief Y Robbins-Juarez, et al.
Kidney International
|
September 24, 2021
Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases
Brad H Rovin, Sharon G Adler, Jonathan Barratt, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
December 31, 2021
A Core Outcome Set for Trials in Glomerular Disease: A Report of the Standardized Outcomes in Nephrology-Glomerular Disease (SONG-GD) Stakeholder Workshops
Simon A Carter, Liz Lightstone, Dan Cattran, et al.
Kidney International
|
May 8, 2021
Development of an international Delphi survey to establish core outcome domains for trials in adults with glomerular disease
Simon A Carter, Charlotte Logeman, Martin Howell, et al.
Kidney International Reports
|
April 29, 2021
Rituximab in Membranous Nephropathy
Philipp Gauckler, Jae Il Shin, Federico Alberici, et al.
Kidney International
|
May 25, 2019
Standardized Outcomes in Nephrology-Glomerular Disease (SONG-GD): establishing a core outcome set for trials in patients with glomerular disease
Simon A Carter, Liz Lightstone, Daniel Cattran, et al.
Nephron
|
June 20, 2015
A Multicenter Randomized Controlled Trial of Rituximab versus Cyclosporine in the Treatment of Idiopathic Membranous Nephropathy (MENTOR)
Fernando C Fervenza, Pietro A Canetta, Sean J Barbour, et al.
Page
of 23
Search research articles
Search
Showing results (201-210 of 225) with videos related to
Sort By:
Page
of 23
Annals of Internal Medicine
|
December 6, 2017
Whole-Exome Sequencing in Adults With Chronic Kidney Disease: A Pilot Study
Sneh Lata, Maddalena Marasa, Yifu Li, et al.
Autoimmunity Reviews
|
September 17, 2020
Rituximab in adult minimal change disease and focal segmental glomerulosclerosis - What is known and what is still unknown?
Philipp Gauckler, Jae Il Shin, Federico Alberici, et al.
Lancet (London, England)
|
November 6, 2023
Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial
Brad H Rovin, Jonathan Barratt, Hiddo J L Heerspink, et al.
Plos One
|
December 28, 2020
High rate of renal recovery in survivors of COVID-19 associated acute renal failure requiring renal replacement therapy
Jacob S Stevens, Kristen L King, Shelief Y Robbins-Juarez, et al.
Kidney International
|
September 24, 2021
Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases
Brad H Rovin, Sharon G Adler, Jonathan Barratt, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
December 31, 2021
A Core Outcome Set for Trials in Glomerular Disease: A Report of the Standardized Outcomes in Nephrology-Glomerular Disease (SONG-GD) Stakeholder Workshops
Simon A Carter, Liz Lightstone, Dan Cattran, et al.
Kidney International
|
May 8, 2021
Development of an international Delphi survey to establish core outcome domains for trials in adults with glomerular disease
Simon A Carter, Charlotte Logeman, Martin Howell, et al.
Kidney International Reports
|
April 29, 2021
Rituximab in Membranous Nephropathy
Philipp Gauckler, Jae Il Shin, Federico Alberici, et al.
Kidney International
|
May 25, 2019
Standardized Outcomes in Nephrology-Glomerular Disease (SONG-GD): establishing a core outcome set for trials in patients with glomerular disease
Simon A Carter, Liz Lightstone, Daniel Cattran, et al.
Nephron
|
June 20, 2015
A Multicenter Randomized Controlled Trial of Rituximab versus Cyclosporine in the Treatment of Idiopathic Membranous Nephropathy (MENTOR)
Fernando C Fervenza, Pietro A Canetta, Sean J Barbour, et al.
Page
of 23